BIOCEPT, INC. Cash, Period Increase (Decrease)
BIOCEPT, INC. reported Cash, Period Increase (Decrease) of $9.17 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Notes
us-gaap:CashPeriodIncreaseDecrease · last filed 2019-08-14
- BIOCEPT, INC. cash, period increase (decrease) for the quarter ending 2019-06-30 was -$2.17M.
- BIOCEPT, INC. cash, period increase (decrease) for the quarter ending 2019-03-31 was $11.34M, a 59.12% increase year-over-year.
- BIOCEPT, INC. cash, period increase (decrease) for the quarter ending 2018-12-31 was -$5.53M.
- BIOCEPT, INC. cash, period increase (decrease) for the quarter ending 2018-09-30 was $6.39M.
- BIOCEPT, INC. cash, period increase (decrease) for fiscal 2018 was $1.28M.
- BIOCEPT, INC. cash, period increase (decrease) for fiscal 2017 was -$2.46M.
- BIOCEPT, INC. cash, period increase (decrease) for fiscal 2016 was -$4.21M, a 221.85% decline from fiscal 2015.
- BIOCEPT, INC. cash, period increase (decrease) for fiscal 2015 was $3.46M.
| Period end | Cash, Period Increase (Decrease) 3 month | Cash, Period Increase (Decrease) 6 month | Cash, Period Increase (Decrease) 9 month | Cash, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-06-30 | -$2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $9.17M 10-Q · filed 2019-08-14 | $3.63M derived: sum of 3 quarters · filed 2019-08-14 | $10.02M derived: sum of 4 quarters · filed 2019-08-14 |
| 2019-03-31 | $11.34M 10-Q · filed 2019-05-14 | $5.81M derived: sum of 2 quarters · filed 2019-05-14 | $12.19M derived: sum of 3 quarters · filed 2019-05-14 | $5.49M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-12-31 | -$5.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $854.26K derived: sum of 2 quarters · filed 2019-03-29 | -$5.85M derived: sum of 3 quarters · filed 2019-08-14 | $1.28M 10-K · filed 2019-03-29 |
| 2018-09-30 | $6.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$316.22K derived: sum of 2 quarters · filed 2019-08-14 | $6.81M 10-Q · filed 2018-11-14 | $3.08M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-06-30 | -$6.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $422.50K 10-Q · filed 2019-08-14 | -$3.31M derived: sum of 3 quarters · filed 2019-08-14 | -$7.43M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $7.13M 10-Q · filed 2019-05-14 | $3.39M derived: sum of 2 quarters · filed 2019-05-14 | -$727.74K derived: sum of 3 quarters · filed 2019-05-14 | -$4.77M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | -$3.73M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$7.85M derived: sum of 2 quarters · filed 2019-03-29 | -$11.90M derived: sum of 3 quarters · filed 2019-03-29 | -$2.46M 10-K · filed 2019-03-29 |
| 2017-09-30 | -$4.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$8.16M derived: sum of 2 quarters · filed 2018-11-14 | $1.27M 10-Q · filed 2018-11-14 | $5.20M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | -$4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $5.39M 10-Q · filed 2018-08-14 | $9.32M derived: sum of 3 quarters · filed 2018-08-14 | $6.25M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $9.43M 10-Q · filed 2018-05-15 | $13.36M derived: sum of 2 quarters · filed 2018-05-15 | $10.29M derived: sum of 3 quarters · filed 2018-05-15 | $9.47M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $857.76K derived: sum of 2 quarters · filed 2018-03-28 | $36.58K derived: sum of 3 quarters · filed 2018-03-28 | -$4.21M 10-K · filed 2018-03-28 |
| 2016-09-30 | -$3.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$3.89M derived: sum of 2 quarters · filed 2017-11-14 | -$8.14M 10-Q · filed 2017-11-14 | |
| 2016-06-30 | -$821.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$5.07M 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | -$4.25M 10-Q · filed 2017-05-15 | |||
| 2015-12-31 | $3.46M 10-K · filed 2017-03-28 |